Orly Lobel analyzes the interplay, at the federal and state levels, of legislative, regulatory, and “new governance” approaches to drug pricing. Read more here.
Orly Lobel analyzes the interplay, at the federal and state levels, of legislative, regulatory, and “new governance” approaches to drug pricing. Read more here.
© 2025 Center for the Study of Federalism. All Rights Reserved.